false
OasisLMS
Skip Navigation Links
About
Membership
Menu
About
Membership
Hamburger Menu
Catalog
Tele-hepatology: Evidence Based and Practical Appl ...
Tele-hepatology: Evidence Based and Practical Applications
Create Account
Availability
Registration Required
https://aasld.zoom.us/j/86564811402
Jul 22, 2025 12:00 PM - 1:00 PM ET
Cost
$0.00
Credit Offered
No Credit Offered
Description
Learning Objectives
Accreditation Information
Faculty and Disclosures
Recommended
This webinar will describe the breadth of telemedicine models, define the role of telemedicine as facilitated in the treatment of viral hepatitis and other liver diseases, identify the barriers that currently exist for implementing telemedicine and create telemedicine strategies to successfully implement into practice. This activity is ideal for healthcare administrators, policymakers, payors, fellows/trainees, gastroenterologists, hepatologists, nurses, nurse practitioners, pharmacists, physician assistants, surgeons, transplant coordinators, and patient advocates.
Upon completion of this activity, participants should be able to:
• Describe the breadth of telemedicine models
• Define the role of telemedicine as facilitated in the treatment of viral hepatitis and other liver diseases
• Identify the barriers that currently exist for implementing telemedicine
• Create telemedicine strategies to successfully implement into practice
The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association for the Study of Liver Diseases designates this blended activity for a maximum of 1.0
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.
The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Andrew Talal, MD, MPH
Scientific Consultant/Advisor:
AbbVie, Regeneron, Gilead, Intercept, Merck, NovoNordisk, Madrigal
Research Grants
: Intercept, Eli Lilly, Bristol Myers-Squibb, Genfit, AstraZeneca, NovoNordisk, Salix
Arpan Dharia, MD
Scientific Consultant/Advisor:
Madrigal, AbbVie
Research Grants:
Kaleida Health Foundation, Patient-Centered Outcomes Research Institute
Arpan Arun Patel, MD, PhD
Nothing to Disclose
George Lyons, JD
Marina Serper, MD
Research Grants
: Eurofins Transplant Genomics, Grifols
Maya Balakrashinan, MD, MPH
Research Grants:
Madrigal, Intercept, Viking Therapeutics, Galmed
Leadership in Society:
Ebix
Pruthvi Patel, MD
Nothing to Disclose
Learning Activity Title
Learning Activity Title
Learning Activity Title
Guideline Updates
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Guideline Update: Acute-on-Chronic Liver Failure
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Guideline Update: Non-Invasive Tests for Hepatic Fibrosis and Steatosis
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Fundamentals of Liver Disease - Hepatitis C 2.0
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Palliative Care and Advanced Liver Disease
Multiple Credits
$0.00 - $200.00
Learning Activity Title
Learning Activity Title
Learning Activity Title
Use of AI in Basic Research (3-Part Series)
No Credit
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
2025 Webinar: Toxic Relationships: When Liver Meets Industrial Chemicals
Multiple Credits
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
2024 Webinar Enduring: World Hepatitis Day – 2024: AASLD - INASL Joint Webinar on Viral Hepatitis
No Credit
FREE
×
Tele-hepatology: Evidence Based and Practical Applications Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English